Literature DB >> 20668483

Carving the CAR.

S R Riddell, U Protzer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20668483      PMCID： PMC6953742          DOI： 10.1038/gt.2010.96

Source DB:  PubMed          Journal:  Gene Ther        ISSN： 0969-7128            Impact factor:   5.250


× No keyword cloud information.
  12 in total

1.  Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2.

Authors:  Richard A Morgan; James C Yang; Mio Kitano; Mark E Dudley; Carolyn M Laurencot; Steven A Rosenberg
Journal:  Mol Ther       Date:  2010-02-23       Impact factor: 11.454

2.  Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCRzeta /CD28 receptor.

Authors:  John Maher; Renier J Brentjens; Gertrude Gunset; Isabelle Rivière; Michel Sadelain
Journal:  Nat Biotechnol       Date:  2002-01       Impact factor: 54.908

3.  Treatment of chronic lymphocytic leukemia with genetically targeted autologous T cells: case report of an unforeseen adverse event in a phase I clinical trial.

Authors:  Renier Brentjens; Raymond Yeh; Yvette Bernal; Isabelle Riviere; Michel Sadelain
Journal:  Mol Ther       Date:  2010-04       Impact factor: 11.454

4.  Coupling CD28 co-stimulation to immunoglobulin T-cell receptor molecules: the dynamics of T-cell proliferation and death.

Authors:  E J Beecham; Q Ma; R Ripley; R P Junghans
Journal:  J Immunother       Date:  2000 Nov-Dec       Impact factor: 4.456

5.  Integrated src kinase and costimulatory activity enhances signal transduction through single-chain chimeric receptors in T lymphocytes.

Authors:  T L Geiger; P Nguyen; D Leitenberg; R A Flavell
Journal:  Blood       Date:  2001-10-15       Impact factor: 22.113

6.  T-cell activation by recombinant receptors: CD28 costimulation is required for interleukin 2 secretion and receptor-mediated T-cell proliferation but does not affect receptor-mediated target cell lysis.

Authors:  A Hombach; D Sent; C Schneider; C Heuser; D Koch; C Pohl; B Seliger; H Abken
Journal:  Cancer Res       Date:  2001-03-01       Impact factor: 12.701

7.  Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity.

Authors:  G Gross; T Waks; Z Eshhar
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

8.  T cells redirected against hepatitis B virus surface proteins eliminate infected hepatocytes.

Authors:  Felix Bohne; Markus Chmielewski; Gregor Ebert; Katja Wiegmann; Timo Kürschner; Andreas Schulze; Stephan Urban; Martin Krönke; Hinrich Abken; Ulrike Protzer
Journal:  Gastroenterology       Date:  2007-11-04       Impact factor: 22.682

9.  A spacer region between the single chain antibody- and the CD3 zeta-chain domain of chimeric T cell receptor components is required for efficient ligand binding and signaling activity.

Authors:  D Moritz; B Groner
Journal:  Gene Ther       Date:  1995-10       Impact factor: 5.250

10.  Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma.

Authors:  Martin A Pule; Barbara Savoldo; G Doug Myers; Claudia Rossig; Heidi V Russell; Gianpietro Dotti; M Helen Huls; Enli Liu; Adrian P Gee; Zhuyong Mei; Eric Yvon; Heidi L Weiss; Hao Liu; Cliona M Rooney; Helen E Heslop; Malcolm K Brenner
Journal:  Nat Med       Date:  2008-11-02       Impact factor: 53.440
View more
  4 in total

Review 1.  Living in the liver: hepatic infections.

Authors:  Ulrike Protzer; Mala K Maini; Percy A Knolle
Journal:  Nat Rev Immunol       Date:  2012-02-24       Impact factor: 53.106

Review 2.  Immunology in the clinic review series; focus on cancer: double trouble for tumours: bi-functional and redirected T cells as effective cancer immunotherapies.

Authors:  L A Marr; D E Gilham; J D M Campbell; A R Fraser
Journal:  Clin Exp Immunol       Date:  2012-02       Impact factor: 4.330

Review 3.  Design of therapeutic vaccines: hepatitis B as an example.

Authors:  Sarah Kutscher; Tanja Bauer; Claudia Dembek; Martin Sprinzl; Ulrike Protzer
Journal:  Microb Biotechnol       Date:  2011-09-29       Impact factor: 5.813

4.  Engineering Chimeric Antigen Receptors.

Authors:  S V Kulemzin; V V Kuznetsova; M Mamonkin; A V Taranin; A A Gorchakov
Journal:  Acta Naturae       Date:  2017 Jan-Mar       Impact factor: 1.845
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.